Rothschild Asset Management Inc. Has $30.57 Million Position in Chemours Company (The) (CC)

Rothschild Asset Management Inc. trimmed its position in Chemours Company (The) (NYSE:CC) by 3.1% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 604,107 shares of the specialty chemicals company’s stock after selling 19,496 shares during the quarter. Rothschild Asset Management Inc. owned about 0.33% of Chemours Company (The) worth $30,574,000 at the end of the most recent quarter.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. Pacer Advisors Inc. increased its holdings in Chemours Company (The) by 16.9% in the 3rd quarter. Pacer Advisors Inc. now owns 29,380 shares of the specialty chemicals company’s stock worth $1,487,000 after acquiring an additional 4,257 shares in the last quarter. Chartwell Investment Partners LLC grew its holdings in Chemours Company (The) by 4.6% during the 3rd quarter. Chartwell Investment Partners LLC now owns 137,688 shares of the specialty chemicals company’s stock valued at $6,968,000 after buying an additional 6,002 shares in the last quarter. Columbus Circle Investors grew its holdings in Chemours Company (The) by 173.2% during the 3rd quarter. Columbus Circle Investors now owns 1,022,466 shares of the specialty chemicals company’s stock valued at $51,747,000 after buying an additional 648,200 shares in the last quarter. Macquarie Group Ltd. grew its holdings in Chemours Company (The) by 44.1% during the 3rd quarter. Macquarie Group Ltd. now owns 82,579 shares of the specialty chemicals company’s stock valued at $4,179,000 after buying an additional 25,279 shares in the last quarter. Finally, Ameriprise Financial Inc. grew its holdings in Chemours Company (The) by 19.2% during the 3rd quarter. Ameriprise Financial Inc. now owns 697,759 shares of the specialty chemicals company’s stock valued at $35,314,000 after buying an additional 112,512 shares in the last quarter. 74.04% of the stock is owned by institutional investors.

In other Chemours Company (The) news, insider E Bryan Snell sold 13,000 shares of the firm’s stock in a transaction dated Tuesday, September 5th. The stock was sold at an average price of $49.35, for a total value of $641,550.00. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, SVP David C. Shelton sold 5,908 shares of the firm’s stock in a transaction dated Friday, October 13th. The stock was sold at an average price of $56.01, for a total value of $330,907.08. Following the completion of the sale, the senior vice president now directly owns 47,356 shares of the company’s stock, valued at approximately $2,652,409.56. The disclosure for this sale can be found here. Insiders sold 76,520 shares of company stock worth $4,008,293 in the last quarter. 1.14% of the stock is owned by insiders.

A number of brokerages have issued reports on CC. Zacks Investment Research raised shares of Chemours Company (The) from a “hold” rating to a “buy” rating and set a $57.00 price objective for the company in a report on Thursday, November 9th. Barclays PLC increased their price objective on shares of Chemours Company (The) from $55.00 to $58.00 and gave the company an “overweight” rating in a report on Monday, November 6th. UBS AG increased their price objective on shares of Chemours Company (The) from $50.00 to $59.00 and gave the company a “neutral” rating in a report on Friday, November 3rd. BidaskClub raised shares of Chemours Company (The) from a “hold” rating to a “buy” rating in a report on Thursday, August 24th. Finally, Argus reaffirmed a “buy” rating and set a $55.00 price objective (up from $50.00) on shares of Chemours Company (The) in a report on Thursday, August 10th. One investment analyst has rated the stock with a hold rating and ten have given a buy rating to the company’s stock. The company has a consensus rating of “Buy” and a consensus target price of $53.89.

WARNING: “Rothschild Asset Management Inc. Has $30.57 Million Position in Chemours Company (The) (CC)” was first posted by StockNewsTimes and is the property of of StockNewsTimes. If you are accessing this news story on another site, it was stolen and republished in violation of United States and international copyright and trademark legislation. The legal version of this news story can be read at https://stocknewstimes.com/2017/11/22/rothschild-asset-management-inc-has-30-57-million-position-in-chemours-company-the-cc.html.

Chemours Company (NYSE CC) traded up $1.04 during mid-day trading on Wednesday, reaching $52.97. The company’s stock had a trading volume of 2,146,800 shares, compared to its average volume of 2,726,338. The company has a debt-to-equity ratio of 5.07, a quick ratio of 1.63 and a current ratio of 2.19. Chemours Company has a twelve month low of $20.76 and a twelve month high of $58.08. The stock has a market capitalization of $9,615.52, a price-to-earnings ratio of 18.42, a price-to-earnings-growth ratio of 0.90 and a beta of 3.59.

Chemours Company (The) (NYSE:CC) last announced its quarterly earnings results on Thursday, November 2nd. The specialty chemicals company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.01 by $0.11. Chemours Company (The) had a return on equity of 116.80% and a net margin of 4.86%. The firm had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same quarter last year, the firm posted $0.61 earnings per share. The business’s revenue for the quarter was up 13.3% on a year-over-year basis. equities research analysts forecast that Chemours Company will post 3.73 earnings per share for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 15th. Shareholders of record on Monday, November 20th will be paid a $0.03 dividend. The ex-dividend date of this dividend is Friday, November 17th. This represents a $0.12 annualized dividend and a yield of 0.23%. Chemours Company (The)’s dividend payout ratio (DPR) is presently 8.28%.

Chemours Company (The) Profile

The Chemours Company is a provider of performance chemicals. The Company operates through three segments: Titanium Technologies, Fluoroproducts and Chemical Solutions. The Titanium Technologies segment is a producer of titanium dioxide (TiO2). The Fluoroproducts segment is a provider of fluoroproducts, including refrigerants and industrial fluoropolymer resins.

Institutional Ownership by Quarter for Chemours Company (The) (NYSE:CC)

Receive News & Ratings for Chemours Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemours Company (The) and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply